153 related articles for article (PubMed ID: 28434690)
21. miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1.
Wang Y; Zhang Z; Wang H; Zhang Y; Ji M; Xu H; Wang C; Sun Z; Gao W; Wang SL
Arch Toxicol; 2016 May; 90(5):1239-49. PubMed ID: 26084420
[TBL] [Abstract][Full Text] [Related]
22. microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.
de Gonzalo-Calvo D; Cenarro A; Civeira F; Llorente-Cortes V
Clin Investig Arterioscler; 2016; 28(4):167-77. PubMed ID: 27363781
[TBL] [Abstract][Full Text] [Related]
23. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Vero cells.
Swanson SK; Mento SJ; Weeks-Levy C; Brock BD; Kowal KJ; Wallace RE; Ritchey MB; Cano FR
J Biol Stand; 1988 Oct; 16(4):311-20. PubMed ID: 3198660
[TBL] [Abstract][Full Text] [Related]
25. Scanning and transmission electron microscopy of transformed Vero cells, with altered in vitro growth characteristics.
Genari SC; Dolder MA; Wada ML
J Submicrosc Cytol Pathol; 1996 Oct; 28(4):565-72. PubMed ID: 8933740
[TBL] [Abstract][Full Text] [Related]
26. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
Petriella D; De Summa S; Lacalamita R; Galetta D; Catino A; Logroscino AF; Palumbo O; Carella M; Zito FA; Simone G; Tommasi S
Tumour Biol; 2016 Apr; 37(4):5503-13. PubMed ID: 26566629
[TBL] [Abstract][Full Text] [Related]
27. Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.
Li Y; Zhang Z
Sci Rep; 2014 Nov; 4():7097. PubMed ID: 25403569
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.
Rane JK; Scaravilli M; Ylipää A; Pellacani D; Mann VM; Simms MS; Nykter M; Collins AT; Visakorpi T; Maitland NJ
Eur Urol; 2015 Jan; 67(1):7-10. PubMed ID: 25234358
[TBL] [Abstract][Full Text] [Related]
29. Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells.
Butkytė S; Čiupas L; Jakubauskienė E; Vilys L; Mocevicius P; Kanopka A; Vilkaitis G
Clin Epigenetics; 2016; 8():33. PubMed ID: 27019673
[TBL] [Abstract][Full Text] [Related]
30. The Rat microRNA body atlas; Evaluation of the microRNA content of rat organs through deep sequencing and characterization of pancreas enriched miRNAs as biomarkers of pancreatic toxicity in the rat and dog.
Smith A; Calley J; Mathur S; Qian HR; Wu H; Farmen M; Caiment F; Bushel PR; Li J; Fisher C; Kirby P; Koenig E; Hall DG; Watson DE
BMC Genomics; 2016 Aug; 17(1):694. PubMed ID: 27576563
[TBL] [Abstract][Full Text] [Related]
31. Identification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex Tissues.
Veeranagouda Y; Rival P; Prades C; Mariet C; Léonard JF; Gautier JC; Zhou X; Wang J; Li B; Ozoux ML; Boitier E
PLoS One; 2015; 10(11):e0142708. PubMed ID: 26562842
[TBL] [Abstract][Full Text] [Related]
32. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
[TBL] [Abstract][Full Text] [Related]
33. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
34. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
36. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
[TBL] [Abstract][Full Text] [Related]
37. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
Guan L; Tan J; Li H; Jin X
Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
[TBL] [Abstract][Full Text] [Related]
38. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
39. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
[TBL] [Abstract][Full Text] [Related]
40. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]